Canadian MMJ Company Offers Nation’s First High-CBG Strain
Whistler Medical Marijuana Corporation has released Canada’s first high cannabigerol (CBG) oil. While CBG is not as well studied as other cannabinoids like THC and CBD, research shows it can be effective in fighting inflammation, nausea, and pain, as well as slowing the spread of cancer cells. The oil, available only to Whistler’s patients, has a THC:CBG ratio of 3:2.
The company plans to study the effects of the oil in order to fine tune later formulations. We know that with cannabis, much of the medical efficacy comes from the entourage effect, a term used to describe the way the many cannabinoids and terpenes work together to give cannabis its medical properties. This type of oil represents an early step in the process of optimizing these medicines.